EXFY vs. RDVT, SMWB, OSPN, BMBL, ECX, KIND, RCAT, PUBM, SLP, and DOMO
Should you be buying Expensify stock or one of its competitors? The main competitors of Expensify include Red Violet (RDVT), Similarweb (SMWB), OneSpan (OSPN), Bumble (BMBL), ECARX (ECX), Nextdoor (KIND), Red Cat (RCAT), PubMatic (PUBM), Simulations Plus (SLP), and Domo (DOMO). These companies are all part of the "computer software" industry.
Expensify vs. Its Competitors
Expensify (NASDAQ:EXFY) and Red Violet (NASDAQ:RDVT) are both small-cap business services companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, dividends, earnings, valuation, institutional ownership, profitability, analyst recommendations, community ranking and media sentiment.
Red Violet received 45 more outperform votes than Expensify when rated by MarketBeat users. Likewise, 62.26% of users gave Red Violet an outperform vote while only 34.43% of users gave Expensify an outperform vote.
In the previous week, Red Violet had 3 more articles in the media than Expensify. MarketBeat recorded 8 mentions for Red Violet and 5 mentions for Expensify. Red Violet's average media sentiment score of 1.30 beat Expensify's score of -0.42 indicating that Red Violet is being referred to more favorably in the news media.
68.4% of Expensify shares are held by institutional investors. Comparatively, 63.6% of Red Violet shares are held by institutional investors. 12.3% of Expensify shares are held by company insiders. Comparatively, 8.9% of Red Violet shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Expensify has a beta of 1.69, meaning that its stock price is 69% more volatile than the S&P 500. Comparatively, Red Violet has a beta of 1.78, meaning that its stock price is 78% more volatile than the S&P 500.
Expensify currently has a consensus target price of $4.00, suggesting a potential upside of 64.61%. Given Expensify's stronger consensus rating and higher possible upside, equities research analysts clearly believe Expensify is more favorable than Red Violet.
Red Violet has a net margin of 7.17% compared to Expensify's net margin of -11.81%. Red Violet's return on equity of 6.80% beat Expensify's return on equity.
Red Violet has lower revenue, but higher earnings than Expensify. Expensify is trading at a lower price-to-earnings ratio than Red Violet, indicating that it is currently the more affordable of the two stocks.
Summary
Red Violet beats Expensify on 12 of the 18 factors compared between the two stocks.
Get Expensify News Delivered to You Automatically
Sign up to receive the latest news and ratings for EXFY and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding EXFY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Expensify Competitors List
Related Companies and Tools
This page (NASDAQ:EXFY) was last updated on 6/12/2025 by MarketBeat.com Staff